Signage for Novartis AG at a building in the company's headquarters campus in Basel, Switzerland, on Monday, Jan. 8, 2023.
Shares of Swiss drugmaker Novartis climbed as much as 4.8% in early deals on Tuesday, after the company raised its full-year guidance following better-than-expected first-quarter results.
Novartis' net sales rose 11% in the first three months of the year, while core operating income increased 22% over the same period.
Narasimhan said the company continued to advance its drug pipeline in the first quarter, including treatments for prostate cancer and leukemia.
"The momentum in our business and pipeline gives us continued confidence in our mid- and long-term growth outlook," he said.
Persons:
Vas Narasimhan, Narasimhan
Organizations:
Novartis AG, Swiss, Novartis
Locations:
company's, Basel, Switzerland, London